Bora CDMO Bora CDMO

X

Find Nesolicaftor manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

PTI-428
Also known as: Pti-428, 1953130-87-4, Nesolicitor, Nesolicaftor [usan], T2u4za62u4, Nesolicaftor (usan)
Molecular Formula
C18H18N4O4
Molecular Weight
354.4  g/mol
InChI Key
XPEHHUISIBFLHX-QFWMXSHPSA-N
FDA UNII
T2U4ZA62U4

PTI-428 is under investigation in clinical trial NCT03258424 (Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis on KALYDECO as Background Therapy).
1 2D Structure

PTI-428

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[3-[5-[(1R)-1-hydroxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide
2.1.2 InChI
InChI=1S/C18H18N4O4/c1-10(23)17-20-21-18(25-17)12-7-13(8-12)19-16(24)15-9-14(22-26-15)11-5-3-2-4-6-11/h2-6,9-10,12-13,23H,7-8H2,1H3,(H,19,24)/t10-,12?,13?/m1/s1
2.1.3 InChI Key
XPEHHUISIBFLHX-QFWMXSHPSA-N
2.1.4 Canonical SMILES
CC(C1=NN=C(O1)C2CC(C2)NC(=O)C3=CC(=NO3)C4=CC=CC=C4)O
2.1.5 Isomeric SMILES
C[C@H](C1=NN=C(O1)C2CC(C2)NC(=O)C3=CC(=NO3)C4=CC=CC=C4)O
2.2 Other Identifiers
2.2.1 UNII
T2U4ZA62U4
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Pti-428

2. 1953130-87-4

3. Nesolicitor

4. Nesolicaftor [usan]

5. T2u4za62u4

6. Nesolicaftor (usan)

7. N-[3-[5-[(1r)-1-hydroxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide

8. 5-isoxazolecarboxamide, N-(trans-3-(5-((1r)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenyl-

9. N-(trans-3-(5-((1r)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenyl-5-isoxazolecarboxamide

10. N-(trans-3-(5-((r)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide

11. Nesolicaftor [inn]

12. Unii-t2u4za62u4

13. Nesolicaftor [who-dd]

14. Chembl4297479

15. Schembl17874059

16. Schembl17874060

17. Schembl17883798

18. Schembl17883826

19. Glxc-25543

20. Pti-428(pti428)

21. Ex-a3723

22. S6911

23. Who 11277

24. Db15239

25. Hy-111680

26. Cs-0090368

27. D11682

28. D87157

2.4 Create Date
2016-08-06
3 Chemical and Physical Properties
Molecular Weight 354.4 g/mol
Molecular Formula C18H18N4O4
XLogP31.4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count5
Exact Mass354.13280507 g/mol
Monoisotopic Mass354.13280507 g/mol
Topological Polar Surface Area114 Ų
Heavy Atom Count26
Formal Charge0
Complexity496
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY